Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does early abciximab improve angiographic outcome and left ventricular function in patients with acute MI?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 536–537 (2007)Cite this article

boxed-textMaioli M et al. (2007) Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial). J Am Coll Cardiol 49: 1517–1524

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hamm CW et al. (1999) Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. N Engl J Med 340: 1623–1629

    Article  CAS  Google Scholar 

  2. De Luca G et al. (2005) Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293: 1759–1765

    Article  CAS  Google Scholar 

  3. van den Merkhof LF et al. (1999) Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study. J Am Coll Cardiol 33: 1528–1532

    Article  CAS  Google Scholar 

  4. De Luca G et al. (2005) Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thromb Haemost 93: 820–823

    Article  CAS  Google Scholar 

  5. Montalescot G et al. (2007) Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up. Eur Heart J 28: 443–449

    Article  CAS  Google Scholar 

  6. Montalescot G et al. (2004) Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis. JAMA 292: 362–366

    Article  CAS  Google Scholar 

  7. Gödicke J et al. (2005) Early versus periprocedural administration of abciximab for primary angioplasty: a pooled analysis of 6 studies. Am Heart J 150: 1015–1017

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Thoraxcenter, Erasmus Medical Center, Room H560, PO Box 2040, Rotterdam, 3000 CA, The Netherlands m.simoons@erasmusmc.nl

Authors and Affiliations

  1. Head of the Cardiology Department at the Thoraxcenter, ML Simoons is Professor of Cardiology, and Chairman of the Cardiovascular Research School (COEUR) at Erasmus University, Rotterdam, The Netherlands.,

    Maarten L Simoons

Authors
  1. Maarten L Simoons
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simoons, M. Does early abciximab improve angiographic outcome and left ventricular function in patients with acute MI?. Nat Rev Cardiol 4, 536–537 (2007). https://doi.org/10.1038/ncpcardio0962

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0962

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing